These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10822220)

  • 1. Relationship between autoantibodies against glutamic acid decarboxylase, thyroglobulin/thyroid microsome and DNA topoisomerase II in the clinical manifestation of patients with type 1 diabetes mellitus in Taiwan.
    Shiau MY; Tsai ST; Hwang J; Wu CY; Chang YH
    Eur J Endocrinol; 2000 Jun; 142(6):577-85. PubMed ID: 10822220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of human DNA topoisomerase II as an autoantigen recognized by patients with IDDM.
    Chang YH; Hwang J; Shang HF; Tsai ST
    Diabetes; 1996 Apr; 45(4):408-14. PubMed ID: 8603760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to thyroid peroxidase in patients with type 1 diabetes in Taiwan.
    Chang CC; Huang CN; Chuang LM
    Eur J Endocrinol; 1998 Jul; 139(1):44-8. PubMed ID: 9703377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies.
    Rattarasarn C; Diosdado MA; Ortego J; Leelawattana R; Soonthornpun S; Setasuban W; Jaruratanasirikul S; Patarakijvanich N
    Diabetes Res Clin Pract; 2000 Aug; 49(2-3):107-11. PubMed ID: 10963821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus.
    Bárová H; Perusicová J; Hill M; Sterzl I; Vondra K; Masek Z
    Physiol Res; 2004; 53(3):279-86. PubMed ID: 15209535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against IA-2, GAD, and topoisomerase II in type 1 diabetic patients.
    Chang YH; Shiau MY; Tsai ST; Lan MS
    Biochem Biophys Res Commun; 2004 Jul; 320(3):802-9. PubMed ID: 15240119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
    Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
    Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet cell, thyroid, adrenal and celiac disease related autoantibodies in patients with Type 1 diabetes from Sri Lanka.
    Premawardhana LD; Wijeyaratne CN; Chen S; Wijesuriya M; Illangasekera U; Brooking H; Amoroso M; Jeffreys J; Bolton J; Lazarus JH; Furmaniak J; Rees Smith B
    J Endocrinol Invest; 2006 Dec; 29(11):968-74. PubMed ID: 17259793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GAD65 antibody prevalence and association with thyroid antibodies, HLA-DR in Chinese children with type 1 diabetes mellitus.
    Chen BH; Chung SB; Chiang W; Chao MC
    Diabetes Res Clin Pract; 2001 Oct; 54(1):27-32. PubMed ID: 11532327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa.
    Panz VR; Kalk WJ; Zouvanis M; Joffe BI
    Diabet Med; 2000 Jul; 17(7):524-7. PubMed ID: 10972582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of thyroid and islet autoantibodies in type 1 diabetes mellitus.
    Prázný M; Skrha J; Límanová Z; Hilgertová J
    Sb Lek; 1999; 100(3):205-11. PubMed ID: 11221467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Takao Y; Yamaguchi Y; Akazawa S; Nagataki S
    Diabetes; 1994 Jan; 43(1):80-6. PubMed ID: 8262321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies.
    Martino GV; Tappaz ML; Braghi S; Dozio N; Canal N; Pozza G; Bottazzo GF; Grimaldi LM; Bosi E
    J Autoimmun; 1991 Dec; 4(6):915-23. PubMed ID: 1812896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-thyroid autoantibodies in children with insulin-dependent diabetes mellitus].
    Smorawińska A; Walczak M; Korman E; Lacka K; Smorawinski J
    Endokrynol Pol; 1989; 40(4):163-70. PubMed ID: 2640200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan.
    Akawaza S; Kawasaki E; Yano M; Abiru N; Yamaguchi Y; Nagataki S
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S89-93. PubMed ID: 7859640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroglobulin and microsomal antibodies in patients with insulin dependent diabetes mellitus and their relatives.
    Nagaoka K; Sakurami T; Nabeya N; Imura H; Kuno S
    Endocrinol Jpn; 1979 Apr; 26(2):213-7. PubMed ID: 477613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon.
    Hawa MI; Picardi A; Costanza F; D'Avola D; Beretta Anguissola G; Guglielmi C; Mottini G; Fezeu L; Mbanya JC; Leslie RD; Pozzilli P
    Clin Immunol; 2006; 118(2-3):229-32. PubMed ID: 16298164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of ICA and GAD antibodies at initial presentation of type 1 diabetes mellitus in Singapore children.
    Lee YS; Ng WY; Thai AC; Lui KF; Loke KY
    J Pediatr Endocrinol Metab; 2001 Jun; 14(6):767-72. PubMed ID: 11453527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender.
    Zimmet PZ; Elliott RB; Mackay IR; Tuomi T; Rowley MJ; Pilcher CC; Knowles WJ
    Diabet Med; 1994 Nov; 11(9):866-71. PubMed ID: 7705024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.